Welcome to our dedicated page for Absci SEC filings (Ticker: ABSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Absci Corporation filings document a Nasdaq-listed clinical-stage biotechnology issuer developing generative AI-designed biologic therapeutics. Its 8-K reports furnish quarterly and annual financial results, business presentations, and internal pipeline updates for programs such as ABS-201 and the broader prolactin and PRLR portfolio.
Proxy and material-event filings cover board and shareholder matters, executive compensation and equity-plan governance, director and officer indemnification agreements, common stock registered on the Nasdaq Global Select Market, and amendments to material agreements related to prior corporate transactions.
Absci Corp Chief Innovation Officer Andreas Busch reported a tax-related share disposition in a Form 4. On March 3, 2026, 1,257 shares of common stock at $2.80 per share were withheld by Absci to cover tax obligations from vesting restricted stock units. This reduced his directly held stake to 321,446 shares. According to the footnote, this was not a discretionary trade but an automatic tax-withholding transaction.
Absci Corp executive reports tax-related share withholding
Absci Corp CFO/CBO Zachariah Jonasson reported a disposition of 8,307 shares of common stock at $2.74 per share. The shares were withheld by the company to cover tax obligations from vesting restricted stock units, not from a discretionary trade. After this, he directly owns 375,231 shares.
Absci Corp executive Zachariah Jonasson, the company’s CFO and CBO, reported a tax-related share disposition. On this Form 4/A, 17,496 shares of common stock were withheld by Absci at a price of $2.99 per share to satisfy tax obligations tied to vesting restricted stock units. After this withholding transaction, Jonasson directly owned 383,538 common shares. The footnote explains that this was not a discretionary trade by Jonasson but an automatic share withholding to cover taxes.
Absci Corp Chief Executive Officer Sean McClain reported a tax-related share disposition connected to vesting restricted stock units. The company withheld 26,761 shares of common stock at a price of $2.99 per share to satisfy withholding obligations, and McClain held 8,334,567 shares directly afterward. The filing specifies this was a tax-withholding event, not a discretionary trade.
Absci Corp director buys additional shares on the open market. Director Menelas N. Pangalos purchased 75,095 shares of Absci Corp common stock in an open-market transaction at a price of $2.74 per share. After this purchase, he directly owns 189,055 common shares.
Absci Corp director and CEO Sean McClain exercised stock options and had shares withheld for taxes. On February 23, 2026, he exercised options to purchase 396,399 shares of common stock at an exercise price of $1.21 per share before their March 3, 2026 expiration.
To cover the option exercise price and applicable tax withholding obligations, 267,008 shares of common stock were disposed of through share withholding, rather than an open-market sale, at $2.65 per share. After these transactions, McClain directly owned 8,463,958 shares of Absci common stock.
Absci Corp’s Chief Innovation Officer, Andreas Busch, reported an automatic share withholding related to equity compensation. On February 3, 2026, 1,469 shares of common stock were withheld by the company at $2.99 per share to satisfy tax obligations from vesting restricted stock units.
Following this tax-withholding event, Busch beneficially owns 322,703 shares of Absci common stock directly. According to the footnote, this transaction did not represent a discretionary trade or open-market sale by the insider.
Absci Corp’s Chief Executive Officer and director Sean McClain reported a transaction involving company common stock. On 02/02/2026, 26,761 shares at $2.99 per share were withheld by Absci to satisfy tax obligations tied to vesting restricted stock units, rather than being sold at his discretion. Following this withholding, McClain directly beneficially owned 8,334,567 common shares of Absci.
Absci Corp executive Jonasson Zachariah, the company’s CFO/CBO, reported a tax-related share withholding on February 2, 2026. Absci withheld 17,496 shares of common stock at $2.99 per share to cover tax obligations arising from the vesting of restricted stock units, which the filing states was not a discretionary trade. After this withholding, Zachariah directly beneficially owned 383,538 shares of Absci common stock.
Absci Corp officer Todd Bedrick reported an automatic share withholding related to equity compensation. On 02/02/2026, 3,659 shares of common stock at $2.99 per share were withheld by Absci to cover tax obligations from vesting restricted stock units. After this tax withholding, Bedrick directly beneficially owned 172,624 common shares. The footnote clarifies this was not a discretionary trade or open-market sale by the reporting person.